Status: Recruiting
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in patients with painful bone metastases.
Participants needed: 33
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Telix Pharmaceuticals (Innovations) Pty LimitedUpdated: May 14, 2026Locations: 6
Eligibility criteria
Participants have had disease progression while on anti-cancer treatment, and ar... [+9]
Participants are pregnant or breastfeeding. [+14]